Willow Biosciences Inc (TSE:WLLW) has released an update.
Willow Biosciences Inc. has successfully completed a brokered private placement, raising over $1.6 million through the sale of units at $0.10 each. The funds are earmarked for product development, including a partnership with Laurus Labs for pharmaceutical ingredients, and for general corporate purposes. The offering also included warrants, allowing investors to purchase additional shares at a set price in the future.
For further insights into TSE:WLLW stock, check out TipRanks’ Stock Analysis page.
